Samples for study ST002523
Species: Homo sapiens (Factor headings shown in green)
| mb_sample_id | Subject name | Sample name | Candida | Sample_Data:RAW_FILE_NAME |
|---|---|---|---|---|
| SA254493 | - | MK175 | High | Gender:Female | Immunotherapy:Pembrolizumab | 220922-LC1-PAN-1-036-SA008762.mzML |
| SA254492 | - | MT239 | High | Gender:Female | Immunotherapy:Pembrolizumab | 220922-LC1-PAN-1-040-SA008755.mzML |
| SA254497 | - | MK209 | High | Gender:Male | Immunotherapy:Nivolumab | 220922-LC1-PAN-1-027-SA008757.mzML |
| SA254495 | - | MK304 | High | Gender:Male | Immunotherapy:Nivolumab | 220922-LC1-PAN-1-026-SA008763.mzML |
| SA254496 | - | MK311 | High | Gender:Male | Immunotherapy:Nivolumab | 220922-LC1-PAN-1-022-SA008767.mzML |
| SA254494 | - | MK329 | High | Gender:Male | Immunotherapy:Nivolumab | 220922-LC1-PAN-1-028-SA008758.mzML |
| SA254501 | - | MK300 | High | Gender:Male | Immunotherapy:Pembrolizumab | 220922-LC1-PAN-1-031-SA008764.mzML |
| SA254499 | - | MK324 | High | Gender:Male | Immunotherapy:Pembrolizumab | 220922-LC1-PAN-1-038-SA008751.mzML |
| SA254500 | - | MT196 | High | Gender:Male | Immunotherapy:Pembrolizumab | 220922-LC1-PAN-1-025-SA008753.mzML |
| SA254498 | - | MT241 | High | Gender:Male | Immunotherapy:Pembrolizumab | 220922-LC1-PAN-1-037-SA008752.mzML |
| SA254503 | - | MK115 | Low | Gender:Female | Immunotherapy:Nivolumab | 220922-LC1-PAN-1-030-SA008756.mzML |
| SA254504 | - | MK227 | Low | Gender:Female | Immunotherapy:Nivolumab | 220922-LC1-PAN-1-039-SA008759.mzML |
| SA254502 | - | MT242 | Low | Gender:Female | Immunotherapy:Nivolumab | 220922-LC1-PAN-1-018-SA008750.mzML |
| SA254505 | - | MK287 | Low | Gender:Female | Immunotherapy:Pembrolizumab | 220922-LC1-PAN-1-019-SA008754.mzML |
| SA254506 | - | MK251 | Low | Gender:Male | Immunotherapy:Nivolumab | 220922-LC1-PAN-1-024-SA008768.mzML |
| SA254509 | - | MT238 | Low | Gender:Male | Immunotherapy:Nivolumab | 220922-LC1-PAN-1-034-SA008749.mzML |
| SA254508 | - | MT245 | Low | Gender:Male | Immunotherapy:Nivolumab | 220922-LC1-PAN-1-033-SA008760.mzML |
| SA254507 | - | MT252 | Low | Gender:Male | Immunotherapy:Nivolumab | 220922-LC1-PAN-1-020-SA008761.mzML |
| SA254510 | - | MK279 | Low | Gender:Male | Immunotherapy:Pembrolizumab | 220922-LC1-PAN-1-032-SA008765.mzML |
